15/04/2008

Court Battle Over Alzheimer's Drug

Almost 100,000 patients a year suffering from Alzheimer's will be refused drugs used by the NHS to fight the disease, the Court of Appeal has been told.

Drugs company EISAI, manufacturer of Aricept, is contesting a decision to restrict access to patients in the later stages of the disease.

The National Institute for Health and Clinical Excellence (Nice) ruled the drugs are not cost effective - a decision upheld by the High Court last year.

Eisai is claiming that Nice did not follow a fair and transparent process in reaching its decision.

The appeal is expected to last two days and judgment will be reserved until next month.

(CD/JM)

Related UK National News Stories
Click here for the latest headlines.

25 September 2015
Further Six Arrested In No Deal Operation In Birmingham
A further six people have been arrested as part of an ongoing operation targeting suspected drug dealers in Birmingham. Police carried out a series of dawn raids on Thursday 24 September, arresting a 17-year-old man, two 19-year-olds and three men aged 21, 26 and 47.
17 October 2003
54 arrested in swoop on suspected drug dealers
Sellers of the Big Issue were among 54 people arrested by Merseyside Police today in a crackdown on drug dealing in Liverpool city centre. Operation Manton targeted suspected drug dealers and drug users and 50 men and four women were arrested following a 15-month long investigation by Merseyside Police into drug dealing on the city's streets.
11 October 2006
Dementia drug appeal rejected
An appeal by Alzheimer's disease groups to win greater access to drugs has been rejected by the NHS watchdog responsible for recommending drugs use. The National institute for Clinical Excellence (NICE) announced that the appeals lodged by stakeholders against draft guidance on the use of drugs to treat Alzheimer�s Disease have not been upheld.
17 April 2009
Older Stroke Patients Get Poorer Treatment, Says BMJ
Older people are less likely to receive drug treatment after a stroke compared to younger people, despite the fact that treatment is equally effective. A study published on bmj.
04 December 2003
Ecstasy in decline but drug use is 'stable'
Class A drug use overall has remained the same but ecstasy use has fallen by a fifth, according to Home Office figures published today. Figures for 2002/03 show that class A drug use among young people has been "broadly stable" since 1996 with recent falls in some individual drugs, such as ecstasy which has fallen for the first time.